Publications - Information

CHI St. Alexius Health First to Offer an Exclusive Human Milk Diet for NICU Patients

baby

CHI St. Alexius Health, one of the largest Level III neonatal intensive care units (NICU) in the state, anticipates improved outcomes for the extremely premature infants with the introduction of an exclusive human milk diet (EHMD)[i] featuring nutritional fortifiers made from 100 percent donor breastmilk instead of cow milk. Keeping extremely premature infants off cow milk-based nutrition has shown to reduce complications[ii], improve health and reduce the length of stay[iii] in the NICU.

Because premature infants require more protein and calories than what breastmilk alone can supply, the American Academy of Pediatrics (AAP) recommends fortifying mother’s milk or pasteurized donor milk with protein, minerals and vitamins to ensure optimal nutrient intake for preemies weighing less than 3 lbs. 4 oz. (1,500 g)[iv].

CHI St. Alexius Health has been a trailblazer in improving the standard of care for preemies and is the first hospital in North Dakota to adopt an EHMD, which comprises moms or donor milk and nutritional fortifiers from Prolacta Bioscience.

When used as part of an EHMD, Prolacta’s fortifiers are clinically proven to improve health outcomes[v],[vi],[vii]and reduce hospital costs3,[viii] for critically ill, extremely premature infants in the NICU weighing less than 2 lbs. 12 oz. (1,250 g) at birth as compared with cow milk-based fortifier or preterm formula.

“We are thrilled to be the only hospital in the region to offer an exclusive human milk diet to all of our tiniest patients, our NICU babies,” stated Nellie Blotter, CHI St. Alexius Health’s NICU Clinical Supervisor. “Research shows fewer complications, which contributes to shorter NICU stays for our patients. I look forward to helping more babies go home sooner and healthier from our NICU.”

In addition to providing the added nutrition preemies need, Prolacta’s fortifiers are the first and only to contain the full spectrum of mother-made human milk oligosaccharides (HMOs) — special sugars found in high concentrations only in breastmilk that serve a predominantly prebiotic and gut maturation function in the newborn gut.[ix],[x] HMOs may be the “secret ingredient” giving breastmilk its myriad health advantages beyond simple nutrition.

 

 

[i] An exclusive human milk diet (EHMD) is achieved when 100% of the protein, fat and carbohydrates in an infant’s diet are derived from human milk. This diet includes a human milk-based human milk fortifier.

[ii] Hair AB, Peluso AM, Hawthorne KM, et al. Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk–based diet. Breastfeed Med. 2016;11(2):70-74doi:10.1089/bfm.2015.0134.

[iii] Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol.2016;36(3):216-220. doi:10.1038/jp.2015.168.

[iv] American Academy of Pediatrics. Breastfeeding and the use of human milk. February 2012. Pediatrics. 129(3): 827-841. doi:10.1542/peds.2011-3552.

[v] Sullivan S, et al. An rexclusively human milk-based diet is associated with a lower ate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. April 2010. 156(4):562-567. doi: 10.1016/j.jpeds.2009.10.040.

[vi] Cristofalo EA, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. December 2013. 163(6):1592-1595. doi: 10.1016/j.jpeds.2013.07.011.

[vii] Abrams SA, et al. Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products.” Breastfeed Med. June 2014. 9(6): 281-0285. doi:10.1089/bfm.2014.0024.

[viii] Ganapathy V, et al. Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants. Breastfeed Med. February 2012. 7(1):29-37. doi: 10.1089/bfm.2011.0002.

[ix] Smilowitz JT, Lebrilla CB, Mills DA, German JB, Freeman SL. Breast milk oligosaccharides: structure-function relationships in the neonate. Annu Rev Nutr. 2014;34:143-69. doi:10.1146/annurev-nutr-071813-105721.

[x] Newberg DS, He Y. Neonatal gut microbiota and human milk glycans cooperate to attenuate infection and inflammation. Clin Obstet Gynecol. 2015;58(4):814-826. doi:10.1097/GRF.0000000000000156.